During the past decade, Houston Methodist Research Institute-CCAT Pearland conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Research Institute-CCAT Pearland" #1 collaborator was "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "University of Minnesota" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Research Institute-CCAT Pearland" are "Diabetic Kidney Disease" (1 trials), "Dyslipidemia" (1 trials), "Heart Failure" (1 trials), "Myocardial Infarction" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Houston Methodist Research Institute-CCAT Pearland" in a lesser frequency.

Most popular intervention types in "Houston Methodist Research Institute-CCAT Pearland" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "High Dose Trivalent Influenza Vaccine" (1 trials), "K-877" (1 trials), "SEL" (1 trials) and "Standard Dose Quadrivalent Influenza Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Research Institute-CCAT Pearland" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Houston Methodist Research Institute-CCAT Pearland". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Houston Methodist Research Institute-CCAT Pearland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Research Institute-CCAT Pearland, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".